Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.42%
Aylık değişim
-11.86%
6 aylık değişim
-38.49%
Yıllık değişim
+6.32%
Önceki kapanış
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Hacim
58
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
VSTM
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
44.51 M
51.49 M
54.95 M
61.55 M
66.78 M
—
Valuation ratios
Enterprise value
19.9 M
177.37 M
213.77 M
91.09 M
451.93 M
934.16 M
Price to earnings ratio
—
-1.41
-1.79
-1.13
-2
-6.34
Price to sales ratio
8.03
18.46
14.85
63.8
36.92
134.03
Price to cash flow ratio
0.71
1.76
1.88
1.56
3.59
8.8
Price to book ratio
0.65
-6.39
-17.08
-7.89
-7.89
-39.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.19
0.64
0.4
0.13
0.56
1.72
Return on equity %
2.17
2.23
1.61
0.72
6.35
10.91
Return on invested capital %
1 018.92
1 043.91
2 007.91
967.24
602.43
4 621.49
Gross margin %
—
—
100
94.01
97.33
—
Operating margin %
—
—
2 419.17
2 047.92
362.17
—
EBITDA margin %
—
—
—
-2 027.09
-344.72
—
Net margin %
—
—
2 853.4
1 213.57
876.34
—
Liquidity ratios
Quick ratio
—
—
—
3.44
2.55
—
Current ratio
3.23
3.07
3.5
3.46
2.58
12.61
Inventory turnover
—
—
—
0.03
0.2
—
Asset turnover
0
0
0.02
0.01
0.06
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.4
0.54
0.38
0.44
1.76
Long term debt to total equity ratio
2.77
1.41
2.2
2.06
5.03
10.71
Per share metrics
Operating cash flow per share
0.59
0.7
0.71
0.44
0.5
2.35
EBIT per share
—
—
—
-0.59
-0.54
—
EBITDA per share
—
—
—
-0.59
-0.53
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.81
2.49
2.17
2.22
1.88
8.76
Net current asset value per share
3
2.66
2.3
2.35
2.11
9.42
Tangible book value per share
0.27
0.81
0.6
0.28
-0.02
1.67
Working capital per share
2.07
1.79
1.64
1.67
1.29
6.4
Book value per share
0.27
0.81
0.6
0.49
0.21
2.11
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Haberler
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley, Verastem hissesi için Al derecelendirmesini yineliyor, 16 dolar hedefini koruyor
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem, kanser tedavisi için 4. çeyrekte 17,5 milyon dolar gelir bildirdi
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Revolution Medicines hisseleri olası AbbVie satın alımıyla %20’den fazla yükseldi
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Mizuho, Verastem için Outperform notunu yineledi